Latest News

Social, behavioral, and environmental factors improved risk prediction beyond genetic scores for 6 common diseases in All of Us data.

The CRL cites deficiencies at a third-party manufacturing facility, with no efficacy or clinical safety deficiencies identified.

SLEEP 2026: GLP-related home sleep testing made up 44% of primary care referrals, but many studies were negative or suboptimal, according to a late-breaking abstract.

FDA approved teplizumab to help preserve insulin production in children with recent-onset stage 3 type 1 diabetes.

SLEEP 2026: In an 8-week randomized trial, reishi mushroom extract reduced Insomnia Severity Index scores more than melatonin in adults with chronic insomnia.

SLEEP 2026: New long-term data showed pitolisant was generally well tolerated and improved symptoms in adults with idiopathic hypersomnia.

SLEEP 2026: Residual cataplexy affected 76.8% of treated adults with narcolepsy type 1 and was linked to greater symptom burden and poorer quality of life.

Prenatal sleep expectations predicted postpartum sleep quality above parity and psychiatric history, with postpartum anxiety further worsening outcomes.